U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C6H15NO3
Molecular Weight 149.1882
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TROLAMINE

SMILES

OCCN(CCO)CCO

InChI

InChIKey=GSEJCLTVZPLZKY-UHFFFAOYSA-N
InChI=1S/C6H15NO3/c8-4-1-7(2-5-9)3-6-10/h8-10H,1-6H2

HIDE SMILES / InChI

Molecular Formula C6H15NO3
Molecular Weight 149.1882
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: Description was created using several sources including: http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/11340s16lbl.pdf; https://www.ons.org/intervention/trolamine-biafine®; https://www.ncbi.nlm.nih.gov/pubmed/?term=15084618; https://clinicaltrials.gov/ct2/show/NCT02729324; http://www.ncbi.nlm.nih.gov/pubmed/18441842

Trolamine, an organic compound, is the salt formed between triethanolamine and salicylic acid. It is widely used as a topical analgesic. 10% trolamine salicylate medical products sold over-the-counter such as are creams for temporarily relief of minor aches and pains of muscles and joints associated with arthritis, simple backache, lumbago, neuralgia, strains, bruises, and sprains. The FDA approved in 1958 otic solution drops containing triethanolamine polypeptide used in the ear to break down and loosen earwax was discontinued. Trolamine can enhance skin healing by recruiting macrophages and modifying the concentrations of various immunomodulators. Trolamine (Biafine; Genmedix Ltd, France) is commonly prescribed at the beginning of radiotherapy for preventing acute radiation-induced skin toxicity in China. Biafine has been studied in radiodermatitis and Phase 2 clinical trial has been initiated in 2016 by Sun Yat-sen University to establish the efficacy of trolamine (Biafine) for the management of radiation dermatitis in patients with nasopharyngeal carcinoma receiving IMRT.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Inactive ingredient
Volu-Firm

Approved Use

Unknown
Palliative
CERUMENEX

Approved Use

For removal of impacted cerumen prior to ear examination, otologic therapy and/or audiometry. CERUMENEX Eardrops should be used only with caution in external otitis.

Launch Date

1958
Doses

Doses

DosePopulationAdverse events​
5.38 mg 2 times / day multiple, topical
Studied dose
Dose: 5.38 mg, 2 times / day
Route: topical
Route: multiple
Dose: 5.38 mg, 2 times / day
Sources:
unhealthy, 21.6–84.9
n = 15
Health Status: unhealthy
Condition: Wound
Age Group: 21.6–84.9
Sex: M+F
Population Size: 15
Sources:
Disc. AE: Application site erythema...
AEs leading to
discontinuation/dose reduction:
Application site erythema (6.7%)
Sources:
AEs

AEs

AESignificanceDosePopulation
Application site erythema 6.7%
Disc. AE
5.38 mg 2 times / day multiple, topical
Studied dose
Dose: 5.38 mg, 2 times / day
Route: topical
Route: multiple
Dose: 5.38 mg, 2 times / day
Sources:
unhealthy, 21.6–84.9
n = 15
Health Status: unhealthy
Condition: Wound
Age Group: 21.6–84.9
Sex: M+F
Population Size: 15
Sources:
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Enantioselective separation of epoxides by capillary electrophoresis employing sulfated beta-cyclodextrin as chiral selector.
2001 Apr
Comparative studies of various run buffers for chiral capillary electrophoresis using chiral crown ether as a chiral selector.
2001 Dec
Bis(triethanolamine)cadmium(II) and -mercury(II) saccharinates: seven-coordinate complexes containing both tri- and tetradentate triethanolamine ligands.
2001 Dec
Extraction and separation of cationic surfactants from river sediments: application to a spectrophotometric determination of cationic surfactant in an aquatic environment using membrane filters.
2001 Nov
[Determination of sulfite residues in foods by using the modified rankine apparatus and HPLC].
2001 Oct
Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin.
2002 Apr 2
Quantitation of nicotine in tobacco products by capillary electrophoresis.
2002 Jan-Feb
Amines compounds as inhibitors of PCDD/Fs de novo formation on sintering process fly ash.
2002 Jun 15
Sustaining pattern of phenformin hydrochloride using various polymers and waxes.
2002 Sep-Oct
Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma.
2003 Apr 22
The use of complexation with alkanolamines to facilitate skin permeation of mefenamic acid.
2003 Aug 27
A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro.
2003 Dec 1
Dynamic localization of SPE-9 in sperm: a protein required for sperm-oocyte interactions in Caenorhabditis elegans.
2003 Dec 3
Expression and function of bradykinin receptors in microglia.
2003 Feb 21
A novel two-pore domain K+ channel, TRESK, is localized in the spinal cord.
2003 Jul 25
Preliminary assessment of alginic acid as a factor buffering triethanolamine interacting with artificial skin sebum.
2003 Mar
Substantial increase of the ordering temperature for [MnII/MoIII(CN)7]-based magnets as a function of the 3d ion site geometry: example of two supramolecular materials with Tc = 75 and 106 K.
2003 Mar 10
Modification and validation of the pyromellitic acid electrolyte for the capillary electrophoretic determination of anions.
2003 May 2
Qualitative determination of false-positive effects in the acetylcholinesterase assay using thin layer chromatography.
2003 May-Jun
The effect of pH and triethanolamine on sulfisoxazole complexation with hydroxypropyl-beta-cyclodextrin.
2003 Nov
Extracting material parameters from x-ray attenuation: a CT feasibility study using kilovoltage synchrotron x-rays incident upon low atomic number absorbers.
2003 Oct 21
Determination of alkanolamines in cattails (Typha latifolia) utilizing electrospray ionization with selected reaction monitoring and ion-exchange chromatography.
2004
Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer.
2004 Apr 15
[The problem and improvement of colorimetric method for determination of sulfite in foods containing sulfur compounds].
2004 Dec
Mixture additives inhibit the dermal permeation of the fatty acid, ricinoleic acid.
2004 Feb 28
Physicochemical and crystallographic characterization of mefenamic acid complexes with alkanolamines.
2004 Jan
Rheological characterization of topical carbomer gels neutralized to different pH.
2004 Jul
Lactic acid production with lactate dehydrogenase using the visible light sensitization of zinc porphyrin.
2004 Jul
[Contact sensitization to pharmaceutic aids in dermatologic cosmetic and external use preparations].
2004 May
Titanatranes derailed: static and dynamic triethanolamine slippage induced by polyphenoxide chelation.
2004 Nov 1
A high-nuclearity "Celtic-ring" isopolyoxotungstate, [H12W36O120]12-, that captures trace potassium ions.
2004 Nov 3
Determination of diethanolamine or N-methyldiethanolamine in high ammonium concentration matrices by capillary electrophoresis with indirect UV detection: application to the analysis of refinery process waters.
2004 Sep
Patents

Sample Use Guides

Fill ear canal with ear drops of 10% triethanolamine Polypeptide Oleate-Condensate with the patient’s head tilted at a 45° angle. Insert cotton plug and allow to remain 15-30 minutes. Then gently flush with lukewarm water, using a soft rubber syringe (avoid excessive pressure). Exposure of skin outside the ear to the drug should be avoided. The procedure may be repeated if the first application fails to clear the impaction.
Route of Administration: Otic (auricular)
Penetration of triethanolamine into artificial skin sebum and its uplift were measured using 0.1 M aqueous triethanolamine solution.
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:03:16 GMT 2023
Edited
by admin
on Fri Dec 15 16:03:16 GMT 2023
Record UNII
9O3K93S3TK
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TROLAMINE
EP   HSDB   II   INN   MART.   USP-RS   VANDF   WHO-DD  
INN  
Official Name English
TROLAMINE [MART.]
Common Name English
TROLAMINE [EP MONOGRAPH]
Common Name English
TRIETHANOLAMINE [VANDF]
Common Name English
TROLAMINE [II]
Common Name English
TROLAMINE [HSDB]
Common Name English
TRIETHANOLAMINE [INCI]
Common Name English
ETHANOL, 2,2',2''-NITRILOTRIS-
Systematic Name English
TROLAMINE [EP IMPURITY]
Common Name English
NSC-36718
Code English
Trolamine [WHO-DD]
Common Name English
TRIETHANOLAMINE [IARC]
Common Name English
TROLAMINE [VANDF]
Common Name English
TRIETHANOLAMINE [MI]
Common Name English
TRIETHANOLAMINE
INCI   MI   VANDF  
INCI  
Official Name English
trolamine [INN]
Common Name English
2,2',2''-NITRILOTRIETHANOL
Systematic Name English
Classification Tree Code System Code
WHO-ATC D03AX12
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
EPA PESTICIDE CODE 4208
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
Code System Code Type Description
DRUG CENTRAL
2768
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
ChEMBL
CHEMBL446061
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
MERCK INDEX
m11100
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY Merck Index
WIKIPEDIA
TRIETHANOLAMINE
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
ECHA (EC/EINECS)
203-049-8
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
INN
561
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
CHEBI
28621
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
NCI_THESAURUS
C45678
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
CONCEPT Industrial Aid
EVMPD
SUB12376MIG
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
FDA UNII
9O3K93S3TK
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
EPA CompTox
DTXSID9021392
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
RS_ITEM_NUM
1696958
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
RXCUI
38623
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY RxNorm
DRUG BANK
DB13747
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
SMS_ID
100000079034
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
NSC
36718
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
DAILYMED
9O3K93S3TK
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
MESH
C009546
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
PUBCHEM
7618
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
NCI_THESAURUS
C80948
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
CAS
102-71-6
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
HSDB
893
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
Related Record Type Details
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (GC)
EP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (GC)
EP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (GC)
EP
Related Record Type Details
ACTIVE MOIETY